N Verses Capital, LLC Dexcom Inc Transaction History
N Verses Capital, LLC
- $167 Billion
- Q2 2024
A detailed history of N Verses Capital, LLC transactions in Dexcom Inc stock. As of the latest transaction made, N Verses Capital, LLC holds 3,800 shares of DXCM stock, worth $249,584. This represents 0.26% of its overall portfolio holdings.
Number of Shares
3,800
Previous 1,400
171.43%
Holding current value
$249,584
Previous $194 Million
121.88%
% of portfolio
0.26%
Previous 0.47%
Shares
2 transactions
Others Institutions Holding DXCM
# of Institutions
1,112Shares Held
365MCall Options Held
4.1MPut Options Held
3.65M-
Vanguard Group Inc Valley Forge, PA46.5MShares$3.05 Billion0.1% of portfolio
-
Black Rock Inc. New York, NY34.5MShares$2.27 Billion0.09% of portfolio
-
State Street Corp Boston, MA16.3MShares$1.07 Billion0.08% of portfolio
-
Baillie Gifford & CO15.3MShares$1.01 Billion1.38% of portfolio
-
Capital Research Global Investors Los Angeles, CA11.9MShares$785 Million0.31% of portfolio
About DEXCOM INC
- Ticker DXCM
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 386,257,984
- Market Cap $25.4B
- Description
- DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...